Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pulmonary Arterial Hypertension. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Weinreb amide route for Treprostinil intermediates eliminates heavy metals and cryogenic conditions, ensuring high purity and scalable manufacturing for pulmonary hypertension therapies.
Patent CN118027091A reveals efficient treprostinil route. Offers supply chain reliability and cost reduction in API manufacturing for global partners.